Skip to main content
SupplementScience

AREDS2 Formula Side Effects & Safety

This content is for informational purposes only and does not constitute medical advice. Consult your healthcare provider before starting any supplement. Full disclaimer

Safety Profile

Overall safety rating: Safe with Caution

Potential Side Effects

  • Gastrointestinal upset from high-dose zinc (80 mg)
  • Urinary tract issues reported in some participants in the AREDS trials
  • Copper supplementation required to prevent zinc-induced copper deficiency
  • Skin yellowing at high carotenoid intake (harmless)
  • Mild nausea in some individuals

Drug & Supplement Interactions

  • Zinc may interfere with certain antibiotics (tetracyclines, quinolones) — separate by 2 hours
  • High-dose vitamin E may interact with blood thinners (warfarin)
  • Zinc competes with copper and iron absorption — copper is included to offset this
  • Proton pump inhibitors may reduce zinc absorption

Maximum Dose

Do not exceed: Follow the standard AREDS2 dosage; zinc at 80 mg is already near the upper tolerable limit (40 mg UL, though 80 mg was well-tolerated in the trial)

Full AREDS2 Formula Guide

References

  1. (). Lutein + zeaxanthin and omega-3 fatty acids for age-related macular degeneration: the Age-Related Eye Disease Study 2 (AREDS2) randomized clinical trial. JAMA. DOI
  2. (). Long-term Outcomes of Adding Lutein/Zeaxanthin and ω-3 Fatty Acids to the AREDS Supplements on Age-Related Macular Degeneration Progression: AREDS2 Report 28. JAMA Ophthalmology. DOI
  3. (). A Randomized, Placebo-Controlled, Clinical Trial of High-Dose Supplementation With Vitamins C and E, Beta Carotene, and Zinc for Age-Related Macular Degeneration and Vision Loss: AREDS Report No. 8. Archives of Ophthalmology. DOI